4.0 Article

The efficacy of saxagliptin in T2DM patients with non-alccholic fatty liver disease: preliminary data

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Nonalcoholic Steatofibrosis Independently Predicts Mortality in Nonalcoholic Fatty Liver Disease

Zobair M. Younossi et al.

HEPATOLOGY COMMUNICATIONS (2017)

Article Medicine, Research & Experimental

Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis

Laura J. Dixon et al.

LABORATORY INVESTIGATION (2012)

Article Endocrinology & Metabolism

An Update in Incretin-Based Therapy: A Focus on Dipeptidyl Peptidase 4 Inhibitors

Brian K. Irons et al.

CURRENT DIABETES REVIEWS (2012)

Article Endocrinology & Metabolism

Effects of saxagliptin on β-cell stimulation and insulin secretion in patients with type 2 diabetes

R. R. Henry et al.

DIABETES OBESITY & METABOLISM (2011)

Article Gastroenterology & Hepatology

Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis

Haruko Sugino et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)